Heiner Zimmermann

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Replacement Therapy

Smoking Cessation

Diffuse Large B Cell Lymphoma

Cross Sectional

Top Venues

Journal of medical economics

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Arie Barlev, Heiner Zimmermann, Norma Guzman-Becerra, Aditi Mehta, Baodong Xing, Bérengère Macabeo, Marion Thivolet, M Alan Brookhart
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant. Journal of medical economics 27 (1) (2024)
Arie Barlev, Heiner Zimmermann, Norma Guzman-Becerra, Aditi Mehta, Baodong Xing, Bérengère Macabeo, Marion Thivolet, M Alan Brookhart
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant. Journal of medical economics 27 (1) (2024)
Arie Barlev, Heiner Zimmermann, Norma Guzman-Becerra, Aditi Mehta, Baodong Xing, Bérengère Macabeo, Marion Thivolet, M Alan Brookhart
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant. Journal of medical economics (2024)
Heiner Zimmermann, Mirko Nitsche, Christiane Pott, Petra Reinke, Nina Babel, Robert M Hermann, Ingeborg A Hauser, Dennis Hahn, Matthias Ritgen, Claudia Pietschmann, Wolfram Klapper, Ioannis Anagnostopoulos, Ralf U Trappe, null null
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry. Annals of hematology 100 (8) (2021)